Atopic Dermatitis Clinical Trials in Philadelphia, Pennsylvania

4 studies are recruiting for atopic dermatitis in Philadelphia, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

    The purpose of this study is to learn if the study medicine (PF-08049820) is safe and effective for the treatment of atopic dermatitis (AD), also known as eczema, or atopic eczema. People with this condition may have severe itching and rashes on the skin. The study is seeking participants who: 1. A…

    Stage
    Phase 2
    Ages
    18 to 64
    Site
    Paddington Testing Co, Inc, Philadelphia, Pennsylvania
    Locations
    42 in total
    Run by
    Pfizer

    See if you can join NCT07216027 on ClinicalTrials.gov

  2. FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

    The purpose of the study is to evaluate the safety, tolerability, and pharmacokinetics of escalating single and repeat doses of PF-07832837 in healthy participants and in participants with moderate to severe atopic dermatitis. An additional goal is to assess the pharmacodynamics of PF-07832837 in p…

    Stage
    Phase 1
    Ages
    18 to 70
    Site
    Paddington Testing Company, Philadelphia, Pennsylvania
    Locations
    5 in total
    Run by
    Pfizer

    See if you can join NCT06564389 on ClinicalTrials.gov

  3. Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

    The main aim of the study is to assess real-world effectiveness of nemolizumab in Atopic Dermatitis (AD) as measured by physician assessment and patient reported outcome (PRO) in clinical practice at Month 6.

    Stage
    Not phased
    Ages
    12 and older
    Site
    Galderma Investigational Site 8559, Philadelphia, Pennsylvania
    Locations
    108 in total
    Run by
    Galderma R&D

    See if you can join NCT06988605 on ClinicalTrials.gov

  4. A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis

    The purpose of this study is to assess the safety, tolerability, and preliminary efficacy of a single and multiple SC dose of BxC-I17e in patients with moderate to severe atopic dermatitis (AD)

    Stage
    Phase 1
    Ages
    18 and older
    Site
    University of Pennsylvania, Philadelphia, Pennsylvania
    Locations
    3 in total
    Run by
    Brexogen Inc.

    See if you can join NCT06055361 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.